Genscript Biotech Corporation (HKG:1548)

Hong Kong · Delayed Price · Currency is HKD

11.81

+0.13 (1.11%)

Mar 10, 2026, 3:25 PM HKT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biologics Development Services	95.02M	109.49M	125.01M	81.35M	40.43M
Biologics Development Services Growth	-13.21%	-12.41%	53.67%	101.23%	78.16%
Industrial Synthetic Biology Products	53.69M	43.05M	38.66M	38.57M	28.91M
Industrial Synthetic Biology Products Growth	24.70%	11.35%	0.25%	33.42%	23.94%
Life Science Services and Products	454.95M	412.91M	360.54M	315.79M	249.82M
Life Science Services and Products Growth	10.18%	14.53%	14.17%	26.41%	44.39%
Eliminations	-66.05M	-58.13M	-71.64M	-24.03M	-11.74M
Operation Unit	56.89M	53.15M	56.12M	9.59M	7.76M
Operation Unit Growth	7.02%	-5.29%	485.13%	23.61%	42.92%
Cell Therapy	-	-	117.01M	68.83M	75.68M
Cell Therapy Growth	-	-	70.00%	-9.05%	31.84%
Total	594.49M	560.48M	625.70M	490.10M	390.85M
Total Growth	6.07%	-10.42%	27.67%	25.39%	42.98%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
The United States of America	265.09M	252.45M	332.10M	246.23M	218.88M
The United States of America Growth	5.01%	-23.98%	34.87%	12.49%	29.96%
Others	18.50M	18.28M	14.56M	13.72M	7.44M
Others Growth	1.21%	25.61%	6.07%	84.51%	268.72%
Mainland China	176.88M	167.22M	166.75M	144.35M	98.42M
Mainland China Growth	5.78%	0.28%	15.52%	46.67%	77.42%
Europe	80.93M	69.29M	53.28M	43.40M	34.26M
Europe Growth	16.80%	30.04%	22.76%	26.70%	28.56%
Asia Pacific (Excluding Mainland China)	53.08M	53.23M	59.01M	42.39M	31.85M
Asia Pacific (Excluding Mainland China) Growth	-0.29%	-9.79%	39.22%	33.08%	53.14%
Total	594.49M	560.48M	625.70M	490.10M	390.85M
Total Growth	6.07%	-10.42%	27.67%	25.39%	42.98%

Source: S&P Global Market Intelligence.